| 000 | 01868 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517130644.0 | ||
| 264 | 0 | _c20170726 | |
| 008 | 201707s 0 0 eng d | ||
| 022 | _a1879-3177 | ||
| 024 | 7 |
_a10.1016/j.tiv.2016.12.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, Ming | |
| 245 | 0 | 0 |
_aThe consequence of regional gradients of P-gp and CYP3A4 for drug-drug interactions by P-gp inhibitors and the P-gp/CYP3A4 interplay in the human intestine ex vivo. _h[electronic resource] |
| 260 |
_bToxicology in vitro : an international journal published in association with BIBRA _cApr 2017 |
||
| 300 |
_a26-33 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aColon _xmetabolism |
| 650 | 0 | 4 |
_aCyclosporins _xpharmacology |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP3A _xmetabolism |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP3A Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIleum _xmetabolism |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aIsoquinolines _xpharmacology |
| 650 | 0 | 4 |
_aJejunum _xmetabolism |
| 650 | 0 | 4 |
_aKetoconazole _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aQuinazolines _xpharmacology |
| 650 | 0 | 4 |
_aQuinidine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aVerapamil _xpharmacology |
| 700 | 1 | _ade Graaf, Inge A M | |
| 700 | 1 | _avan de Steeg, Evita | |
| 700 | 1 | _ade Jager, Marina H | |
| 700 | 1 | _aGroothuis, Geny M M | |
| 773 | 0 |
_tToxicology in vitro : an international journal published in association with BIBRA _gvol. 40 _gp. 26-33 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.tiv.2016.12.002 _zAvailable from publisher's website |
| 999 |
_c26685338 _d26685338 |
||